Cohort Study: In Patients with Acute Coronary Syndrome Who Underwent PCI, Use of Ticagrelor was Not Associated with Reduced Coronary Events and Was Associated with More Major Bleeding and Dyspnea When Compared to Clopidogrel

Association of Ticagrelor vs Clopidogrel With Major Adverse Coronary Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention – JAMA Internal Medicine (free for a limited period)

Commentary: Brilinta Questioned for Acute Coronary Syndrome – MedPage Today (free registration required)